BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22897624)

  • 1. Patients' attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis.
    Yuhas J; Mattocks K; Gravelin L; Remetz M; Foley J; Fazio R; Lampert R
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1179-87. PubMed ID: 22897624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study.
    Matlock DD; Nowels CT; Masoudi FA; Sauer WH; Bekelman DB; Main DS; Kutner JS
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1634-44. PubMed ID: 21972983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Gravelin LM; Yuhas J; Remetz M; Radford M; Foley J; Lampert R
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):152-6. PubMed ID: 21304093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.
    Sadarmin PP; Wong KC; Rajappan K; Bashir Y; Betts TR
    Europace; 2014 Nov; 16(11):1575-9. PubMed ID: 24668515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death.
    Carroll SL; Strachan PH; de Laat S; Schwartz L; Arthur HM
    Health Expect; 2013 Mar; 16(1):69-79. PubMed ID: 21645190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.
    Chan LL; Lim CP; Aung ST; Quetua P; Ho KL; Chong D; Teo WS; Sim D; Ching CK
    Singapore Med J; 2016 Apr; 57(4):182-7. PubMed ID: 27075476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiencies in patients' comprehension of implantable cardioverter defibrillator therapy.
    Groarke J; Beirne A; Buckley U; O'Dwyer E; Sugrue D; Keelan T; O'Neill J; Galvin J; Mahon N
    Pacing Clin Electrophysiol; 2012 Sep; 35(9):1097-102. PubMed ID: 22734654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
    Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-ICD illness beliefs affect postimplant perceptions of control and patient quality of life.
    Hallas CN; Burke JL; White DG; Connelly DT
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):256-65. PubMed ID: 20059710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator.
    Dougherty CM; Lewis FM; Thompson EA; Baer JD; Kim W
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1594-602. PubMed ID: 15613121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low referral pattern for implantable defibrillator therapy in a tertiary hospital: referral physician survey and Monte Carlo simulation.
    Mohamad T; Jacob S; Kommuri NV; Modi S; Aravindhakshan R; Lieberman R
    Am J Ther; 2011 Sep; 18(5):350-4. PubMed ID: 20335787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of implantable cardioverter defibrillators in the New Zealand context from 2000 to 2007.
    Larsen PD; De Silva P; Harding SA; Woodcock E; Lever NA
    N Z Med J; 2010 Feb; 123(1309):76-85. PubMed ID: 20186244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-of-life decisions in ICD patients with malignant tumors.
    Kobza R; Erne P
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):845-9. PubMed ID: 17584265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.